Clinical value of 1.5T dynamic enhanced MRI in the differential diagnosis of prostate cancer

Abstract

Objective To analyze the clinical value of 1.5T dynamic enhanced MRI in the differential diagnosis of prostate cancer. Methods A total of 298 patients with prostate disease admitted to Zhejiang Quhua Hospital from January 2017 to December 2017 were enrolled.All subjects underwent MRI(including T2WI, DWI, DCE), and the results of all subjects were observed.The pathological biopsy was used as the gold standard for diagnosis.The possibility of prostate cancer was evaluated. Results Among the 298 patients with prostate disease, there were 136 cases of prostate cancer, including 84 cases of peripheral prostate cancer, the detection rates of T2WI, DWI and DCE were all 100.00%, 52 cases of central gland prostate cancer, the detection rates of T2WI, DWI and DCE were 100.00%, 98.08%, and 98.08%, respectively.Among 298 patients with prostate disease, there were 162 cases of pre-existing adenitis, including 64 cases of peripheral prostatitis.The detection rates of T2WI, DWI and DCE were 98.44%, 100.00%, 96.88%, respectively, 98 cases of central glandular gland inflammation, the detection rates of T2WI, DWI, DCE were 97.96%, 100.00%, 98.98%, respectively. Conclusion 1.5T dynamic enhanced MRI can correctly detect prostate diseases, especially prostate cancer. Key words: Prostate neoplasms; Magnetic resonance imaging; Diagnosis; Pathology, clinical; Biopsy, needle